Literature DB >> 2484402

Selenium supplementation of symptomatic human immunodeficiency virus infected patients.

L Olmsted1, G N Schrauzer, M Flores-Arce, J Dowd.   

Abstract

The mean whole blood selenium levels in male San Diego, CA patients with acquired immune deficiency syndrome (AiDS) are 0.123 +/- 0.030 micrograms/mL (n = 24), and 0.126 +/- 0.038 micrograms/mL (n = 26) in patients with AIDS-related complex (ARC), compared to 0.195 +/- 0.020 micrograms/mL (n = 28) in San Diego healthy controls (males). To establish whether intestinal absorption of dietary selenium is impaired in AIDS or ARC, a supplementation trial was conducted in which 19 symptomatic HIV-antibody positive male patients with AIDS or ARC were taking 400 micrograms of selenium/d in form of selenium yeast for up to 70 d. The mean whole blood Se levels increased to 0.28 +/- 0.08 micrograms/mL after 70 d of supplementation, the selenium supplements were well tolerated. A rationale for adjuvant selenium supplementation of symptomatic and asymptomatic HIV carriers is proposed.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2484402     DOI: 10.1007/bf02919098

Source DB:  PubMed          Journal:  Biol Trace Elem Res        ISSN: 0163-4984            Impact factor:   3.738


  10 in total

Review 1.  Nutritional factors in epidemic Kaposi's sarcoma.

Authors:  N Colman; F Grossman
Journal:  Semin Oncol       Date:  1987-06       Impact factor: 4.929

2.  The racemization rate of selenomethionine and methionine in yeast at 100 degrees C and neutral pH.

Authors:  M F Boehm; J L Bada
Journal:  Anal Biochem       Date:  1985-03       Impact factor: 3.365

3.  Alteration of natural killer cell-mediated cytotoxicity in rats treated with selenium, diethylnitrosamine and ethylnitrosourea.

Authors:  P A Talcott; J H Exon; L D Koller
Journal:  Cancer Lett       Date:  1984-07       Impact factor: 8.679

Review 4.  Selenium and immune responses.

Authors:  L Kiremidjian-Schumacher; G Stotzky
Journal:  Environ Res       Date:  1987-04       Impact factor: 6.498

5.  Selenium deficiency in the acquired immunodeficiency syndrome.

Authors:  B M Dworkin; W S Rosenthal; G P Wormser; L Weiss
Journal:  JPEN J Parenter Enteral Nutr       Date:  1986 Jul-Aug       Impact factor: 4.016

6.  Immune responses in rats supplemented with selenium.

Authors:  L D Koller; J H Exon; P A Talcott; C A Osborne; G M Henningsen
Journal:  Clin Exp Immunol       Date:  1986-03       Impact factor: 4.330

7.  Selenium effects on human neutrophilic granulocyte function in vitro.

Authors:  T Urban; C Jarstrand
Journal:  Immunopharmacology       Date:  1986-10

8.  The response of selenium-deficient mice to Candida albicans infection.

Authors:  R Boyne; J R Arthur
Journal:  J Nutr       Date:  1986-05       Impact factor: 4.798

9.  Abnormalities of blood selenium and glutathione peroxidase activity in patients with acquired immunodeficiency syndrome and aids-related complex.

Authors:  B M Dworkin; W S Rosenthal; G P Wormser; L Weiss; M Nunez; C Joline; A Herp
Journal:  Biol Trace Elem Res       Date:  1988 Jan-Apr       Impact factor: 3.738

10.  Selenium chemoprevention of liver cancer in animals and possible human applications.

Authors:  S Y Yu; Y J Chu; W G Li
Journal:  Biol Trace Elem Res       Date:  1988 Jan-Apr       Impact factor: 3.738

  10 in total
  12 in total

Review 1.  Role of selenium in HIV infection.

Authors:  Cosby A Stone; Kosuke Kawai; Roland Kupka; Wafaie W Fawzi
Journal:  Nutr Rev       Date:  2010-11       Impact factor: 7.110

2.  The mechanism for the effect of selenium supplementation on immunity.

Authors:  E Sun; H Xu; Q Liu; J Zhou; P Zuo; J Wang
Journal:  Biol Trace Elem Res       Date:  1995-06       Impact factor: 3.738

3.  Supplementation with selenium and human immune cell functions. I. Effect on lymphocyte proliferation and interleukin 2 receptor expression.

Authors:  M Roy; L Kiremidjian-Schumacher; H I Wishe; M W Cohen; G Stotzky
Journal:  Biol Trace Elem Res       Date:  1994 Apr-May       Impact factor: 3.738

4.  Supplementation with selenium and human immune cell functions. II. Effect on cytotoxic lymphocytes and natural killer cells.

Authors:  L Kiremidjian-Schumacher; M Roy; H I Wishe; M W Cohen; G Stotzky
Journal:  Biol Trace Elem Res       Date:  1994 Apr-May       Impact factor: 3.738

Review 5.  Selenium and cellular immunity. Evidence that selenoproteins may be encoded in the +1 reading frame overlapping the human CD4, CD8, and HLA-DR genes.

Authors:  E W Taylor
Journal:  Biol Trace Elem Res       Date:  1995 Aug-Sep       Impact factor: 3.738

6.  Modulation of procainamide toxicity by selenium-enriched yeast in rats.

Authors:  M Toborek; K Magner-Wróbel; M Drózdz; A Danch; E Kopieczna-Grzebieniak
Journal:  Arch Toxicol       Date:  1993       Impact factor: 5.153

7.  Relationship of trace element, immunological markers, and HIV1 infection progression.

Authors:  C Allavena; B Dousset; T May; F Dubois; P Canton; F Belleville
Journal:  Biol Trace Elem Res       Date:  1995 Jan-Mar       Impact factor: 3.738

8.  Effect of Human Immunodeficiency Virus on Trace Elements in the Brain.

Authors:  Karen Cilliers; Christo J F Muller
Journal:  Biol Trace Elem Res       Date:  2020-04-01       Impact factor: 3.738

9.  Effect of selenium supplementation on CD4 T-cell recovery, viral suppression, morbidity and quality of life of HIV-infected patients in Rwanda: study protocol for a randomized controlled trial.

Authors:  Julius Kamwesiga; Vincent Mutabazi; Josephine Kayumba; Jean-Claude K Tayari; Richard Smyth; Heather Fay; Alice Umurerwa; Marcel Baziruwiha; Christian Ntizimira; Antoinette Murebwayire; Jean Pierre Haguma; Julienne Nyiransabimana; Donatille Habarurema; Veneranda Mukarukundo; Jean Bosco Nzabandora; Pascal Nzamwita; Ernestine Mukazayire; Edward J Mills; Dugald Seely; Douglas J McCready; Don Warren
Journal:  Trials       Date:  2011-08-13       Impact factor: 2.279

10.  Inhibition of I kappa B-alpha phosphorylation and degradation and subsequent NF-kappa B activation by glutathione peroxidase overexpression.

Authors:  C Kretz-Remy; P Mehlen; M E Mirault; A P Arrigo
Journal:  J Cell Biol       Date:  1996-06       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.